Fri, Jul 25, 2014, 7:45 AM EDT - U.S. Markets open in 1 hr 45 mins

Recent

% | $
Click the to save as a favorite.

American Capital Agency Corp. Message Board

gene4346 95 posts  |  Last Activity: 13 hours ago Member since: Dec 21, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    ????

    by fd4tht56 14 hours ago
    gene4346 gene4346 13 hours ago Flag

    Well done...........my hat off to you.................

    Sentiment: Strong Buy

  • Reply to

    Comparison: GALE's NeuVax vs. Puma's Neratinib

    by gene4346 Jul 23, 2014 9:30 AM
    gene4346 gene4346 Jul 23, 2014 12:56 PM Flag

    up for more constructive comments, comparisons and opinions.........thx.............Gene

    Sentiment: Strong Buy

  • With the big news yesterday at Puma, there may be some people who feel we (GALE) may be "late for the dance". Would anyone like to take a stab at explaining the difference between the two drugs (and their target patients) and why they are not (will not) be competing for the same market/dollars? GLTA longs.............

    Sentiment: Strong Buy

  • gene4346 gene4346 Jul 22, 2014 9:11 PM Flag

    IMHO........Ahn would not have made the deal if it required a Secondary Offering to raise cash to fund it. He is already on the "hot seat" with shareholders so to add fuel to the fire would not be in his best interest. Those kids on MF have yet to have their first wet drm, much-less know what's going on in the real world should be of no concern. I suspect the next time they appear they will be scratching themselves on-air because they are now starting to grow hair they have not it in the past and their voices will be getting changing............enough said...........

    Sentiment: Strong Buy

  • gene4346 gene4346 Jul 22, 2014 7:33 PM Flag

    I'm long and strong.......but right now I want to know where I can buy some of what you are smoking..........glta longs................

    Sentiment: Strong Buy

  • gene4346 gene4346 Jul 22, 2014 7:31 PM Flag

    up, up and away tomorrow..................

    Sentiment: Strong Buy

  • Disregard his trash.........nothing more than a new paid basher full of shttttttttttttt...........

    jayrodman585
    68 posts |
    Last Activity: 3 minutes 36 seconds ago
    Member since: Jul 18, 2014

    Sentiment: Strong Buy

  • Reply to

    Roth Capital Raises Price Target From $7 to $8

    by gene4346 Jul 22, 2014 1:55 PM
    gene4346 gene4346 Jul 22, 2014 6:26 PM Flag

    For anyone who didn't see this earlier................I will believe Analysts Opinion's (due diligence) before some boiler room basher's trash (never facts.....just trash talk)...............GLTA longs..........and remember, we will prevail.....IMHO

    Sentiment: Strong Buy

  • GAINING GREEN – Helping To Make Your Portfolio Ever Green
    Eye Catching Stocks –Galena Biopharma (NASDAQ:GALE)
    Posted by Fran Carter on Jul 22, 2014
    The Annual Meeting of stockholders of Galena Biopharma, Inc. (NASDAQ:GALE) (“we,” “us,” “our” or the “company”) was held on June 27, 2014. On April 30, 2014, we filed with the Securities and Exchange Commission our definitive proxy statement relating to the Annual Meeting. Galena Biopharma, Inc. (NASDAQ:GALE) shares surged 2.95% in last trading session and ended the day at $2.79. GALE Gross Margin is 80.90%. Galena Biopharma, Inc. (NASDAQ:GALE) quarterly performance is 50.81%.

    Sentiment: Strong Buy

  • Reply to

    Roth Capital Raises Price Target From $7 to $8

    by gene4346 Jul 22, 2014 1:55 PM
    gene4346 gene4346 Jul 22, 2014 1:59 PM Flag

    With news like this...........my pleasure.............GLTA longs...................

    Sentiment: Strong Buy

  • Roth Capital Raises PT on Galena (GALE) to $8 Following Zuplenz Licensing News
    July 22, 2014 9:12 AM EDT

    Roth Capital lifts its target price on Galena Biopharma (Nasdaq: GALE) from $7 to $8 and maintains a Buy rating on the company following news that it it has entered into a definitive agreement to license the U.S. rights for the commercial product Zuplenz (ondansetron) oral soluble film.

    Analyst Joseph Pantginis commented, "The addition of Zuplenz to Galena's "sales bag" is an interesting incremental addition to the company's current revenue streams and importantly a represents an easy addition to the current sales reps' marketing of Abstral for breakthrough cancer pain. We are taking a conservative approach to defining the potential market potential for the drug based the crowded nature of the anti-emetic market. To this end, we are currently projecting $20 million in peak sales for the drug for Galena and have made incremental changes to our model. The overall market for 5-HT3 inhibitors (ondansetron) is $1 billion in the U.S. so we believe our $20 million peak sales estimate represents low hanging fruit. We have increased our product revenue projections from $21.4 million to $23.1 million and $35.2 million to $38.4 million for 2015 and 2016 respectively. Regarding the pipeline, management confirmed that the Phase II study of GALE 301 is enrolling better than expected. The NeuVax Phase III enrollment is also going well and the company expects to reach full enrollmen"of 700 patients by YE14. The protocol for the gastric cancer study with partner Dr. Reddy's (RDY-NC) in India is nearing completion."

    For an analyst ratings summary and ratings history on Galena Biopharma click here. For more ratings news on Galena Biopharma click here.

    Galena Biopharma closed at $2.79 yesterday.

    Sentiment: Strong Buy

  • Reply to

    The Street?

    by sicnickatnite Jul 22, 2014 11:54 AM
    gene4346 gene4346 Jul 22, 2014 12:10 PM Flag

    My sentiments exactly............he is lowest form of life on earth...................HOWEVER, his day will come and when it does, he is going to pay dearly...................

    Sentiment: Strong Buy

  • gene4346 gene4346 Jul 22, 2014 11:46 AM Flag

    It's simple.........fagstein can't get it up for his gay lover so he has to try and get one up for GALE...........

    Sentiment: Strong Buy

  • The deal with MonoSol is certainly big news, but if you read what APR does, an indirect relationship with APR through MonoSol may really pave the way for additional opportunities for GALE.......IMHO.....

    About APR Applied Pharma Research

    APR is an independent, international and integrated Healthcare Company headquartered in Switzerland, which focuses on three major areas: Delivering, Funding and Supporting Innovation in Healthcare. In particular, APR develops and licenses innovative, value added and patented healthcare products and proprietary drug delivery systems primarily in the oral and topical fields; APR also invests in companies or early stage innovative projects and provides a balanced mix of equity funding and/or financing together with APR's development, scientific, technical, marketing, licensing and management skills and know how; finally, APR supports biotech and pharmaceutical companies in the development of new pharmaceutical projects by providing on a contract basis added value, consultancy and R&D services under contract using a General Contractor approach. APR has entered into licensing and partnership agreements with pharmaceutical companies in over 100 countries worldwide with international sales on a worldwide basis.

    Sentiment: Strong Buy

  • Reply to

    Zuplenz - Projected Revenue Estimates

    by gene4346 Jul 22, 2014 8:30 AM
    gene4346 gene4346 Jul 22, 2014 9:24 AM Flag

    Thank you all for the feedback.............I can live with all of the numbers you stated..........I assumed (hoped) it was structured such that it was a "win-win" deal..............

    Sentiment: Strong Buy

  • Has anyone seen or heard any projected revenue estimates for Zuplenz? Also, anyone seen or heard what the "upfront payment" is? Whatever it is, I hope it doesn't dig too deep into the cash reserve as I don't even want to mention the "D" word.................GLTA longs..................

    Sentiment: Strong Buy

  • gene4346 gene4346 Jul 21, 2014 4:21 PM Flag

    Well put on all fronts and I think all of your estimates are within reason...........GLTA longs................

    Sentiment: Strong Buy

  • Reply to

    This makes me wonder what Gale is worth.

    by fugitive6129 Jul 21, 2014 2:07 AM
    gene4346 gene4346 Jul 21, 2014 10:33 AM Flag

    Nice catch and great question. I agree with fugitive's comments; GALE has a ton more to offer than Seragon. I know most people want GALE to "go it alone", but for the right price I'd take a buyout in a second.........A bird in the hand (today) is worth two in the bush (tomorrow) as far as I'm concerned.......

    Sentiment: Strong Buy

  • gene4346 by gene4346 Jul 20, 2014 11:23 AM Flag

    techsonian/traders-alert-brookdale-senior-living-inc-bkd-galena-biopharma-inc-gale-st-jude-medical-inc-stj cal-incorporated-vicl/12240730/

    Traders Alert – Brookdale Senior Living, Inc. (BKD), Galena Biopharma Inc (GALE), St. Jude Medical, Inc. (STJ), Vical Incorporated (VICL)

    Submitted By submitted by pennystockchronicle on July 19, 2014 - 01:30 PM

    Galena Biopharma Inc (NASDAQ:GALE), revealed the notice of allowance of a U.S. Patent for NeuVax(TM) (nelipepimut-S) covering the use of NeuVax alone or in combination to prevent recurrence of any HER2/neu expressing tumor having a fluorescence in situ hybridization (FISH) rating of less than about 2.0. NeuVax is a peptide immunotherapy for the prevention of cancer recurrence and is Galena’s lead development agent in multiple ongoing and planned clinical trials. Once issued, the patent will expire in 2028, not including any patent term extensions.
    Galena Biopharma Inc (NASDAQ:GALE) surged 0.54% and closed at $67.14 on a traded volume of 2.07 million shares, whereas its average trading volume is 1.65 million shares. The Intra-day range for the stock is $66.66 and $71.90.

    Sentiment: Strong Buy

  • Reply to

    SEC investigating 10 Hedge Funds, bashers next?

    by jrdelane Jul 19, 2014 7:06 PM
    gene4346 gene4346 Jul 20, 2014 9:40 AM Flag

    It's about frikin' time..............they have cost all of us (longs) lots of mine............GLTA longs and hold, hold, hold.........

    Sentiment: Strong Buy

AGNC
23.45-0.06(-0.26%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.